Design and synthesis of 2-iminothiazolidin-4-one moiety-containing compounds as potent antiproliferative agents.

about

Design and synthesis of 2-iminothiazolidin-4-one moiety-containing compounds as potent antiproliferative agents.

Item

http://www.wikidata.org/entity/Q39416611

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Design and synthesis of 2-imin ...... tent antiproliferative agents.

@en

Design and synthesis of 2-imin ...... tent antiproliferative agents.

@nl

type

Item

label

Design and synthesis of 2-imin ...... tent antiproliferative agents.

@en

Design and synthesis of 2-imin ...... tent antiproliferative agents.

@nl

prefLabel

Design and synthesis of 2-imin ...... tent antiproliferative agents.

@en

Design and synthesis of 2-imin ...... tent antiproliferative agents.

@nl

P1476

Design and synthesis of 2-imin ...... tent antiproliferative agents.

@en

P2093

Dong Chen

http://www.w3.org/2001/XMLSchema#string

Jun Liu

http://www.w3.org/2001/XMLSchema#string

Ping Gong

http://www.w3.org/2001/XMLSchema#string

Ruiwei Lai

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Xin Zhai

http://www.w3.org/2001/XMLSchema#string

P2860

Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells.

4-thiazolidinone--a biologically active scaffold.

Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo.

Design, synthesis, and in vitro antitumor evaluation of novel diaryl ureas derivatives.

Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor.

P304

360-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ARDP.201100064

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

345

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22223396

http://www.w3.org/2001/XMLSchema#string